Cargando…
Chemotherapy for malignant pleural mesothelioma: past results and recent developments
This review summarises the results of previously conducted clinical trials, and subsequently presents data arising from all phase II–III studies on chemotherapy of malignant pleural mesothelioma (MPM) published since the last relevant overview. While response rates exceeding 30% have barely been ach...
Autores principales: | Tomek, S, Emri, S, Krejcy, K, Manegold, C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377054/ https://www.ncbi.nlm.nih.gov/pubmed/12610498 http://dx.doi.org/10.1038/sj.bjc.6600673 |
Ejemplares similares
-
Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018) -
Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021) -
Modern management of malignant pleural mesothelioma
por: Patel, Shivani C, et al.
Publicado: (2016) -
Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009) -
Hedgehog Signaling in Malignant Pleural Mesothelioma
por: Felley-Bosco, Emanuela, et al.
Publicado: (2015)